Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.

MLA

Elsayed, Mohammad, et al. “Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.” CardioVascular & Interventional Radiology, vol. 44, no. 12, Dec. 2021, pp. 1937–44. EBSCOhost, https://doi.org/10.1007/s00270-021-02916-z.

APA

Elsayed, M., Wagstaff, W., Behbahani, K., Villalobos, A., Bercu, Z., Majdalany, B. S., Akce, M., Schuster, D. M., Mao, H., & Kokabi, N. (2021). Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma. CardioVascular & Interventional Radiology, 44(12), 1937–1944. https://doi.org/10.1007/s00270-021-02916-z

Chicago

Elsayed, Mohammad, William Wagstaff, Keywan Behbahani, Alexander Villalobos, Zachary Bercu, Bill S. Majdalany, Mehmet Akce, David M. Schuster, Hui Mao, and Nima Kokabi. 2021. “Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.” CardioVascular & Interventional Radiology 44 (12): 1937–44. doi:10.1007/s00270-021-02916-z.